def investigate_innovative_treatments(disease_name, standard_of_care_context=None):
    """
    Systematic research framework for innovative treatment investigation.
    
    Args:
        disease_name: Target disease/condition
        standard_of_care_context: Known limitations of current standard treatment
    
    Returns:
        Confidence-weighted knowledge base with therapeutic patterns
    """
    
    research_domains = {
        'immunotherapy': {
            'sub_topics': ['CAR-T cell therapy', 'dendritic cell vaccines', 
                          'checkpoint inhibitors', 'bispecific antibodies',
                          'mRNA vaccines', 'adoptive cell transfer'],
            'key_metrics': ['overall_survival', 'progression_free_survival',
                           'objective_response_rate', 'clinical_trial_phase'],
            'pattern_focus': 'neoadjuvant_vs_adjuvant_timing, local_vs_systemic_delivery'
        },
        'viral_and_gene_therapy': {
            'sub_topics': ['oncolytic viruses', 'CRISPR gene therapy',
                          'viral vectors', 'gene editing approaches'],
            'key_metrics': ['viral_strain_efficacy', 'safety_profile',
                           'delivery_method_outcomes', 'regulatory_status'],
            'pattern_focus': 'tumor_selectivity, immune_activation_mechanism'
        },
        'drug_delivery_innovation': {
            'sub_topics': ['nanoparticles', 'convection_enhanced_delivery',
                          'BBB_disruption', 'focused_ultrasound',
                          'local_implant_delivery'],
            'key_metrics': ['CNS_penetration_rate', 'bioavailability',
                           'safety_profile', 'delivery_efficiency'],
            'pattern_focus': 'local_delivery_advantage, BBB_penetration_strategies'
        },
        'targeted_molecular_therapy': {
            'sub_topics': ['kinase_inhibitors', 'mutation_specific_therapies',
                          'metabolic_vulnerabilities', 'signaling_pathway_inhibitors',
                          'synthetic_lethality_pairs'],
            'key_metrics': ['molecular_response_rate', 'biomarker_prediction',
                           'resistance_mechanisms', 'combination_potential'],
            'pattern_focus': 'actionable_mutations, resistance_pathways'
        },
        'combination_and_microenvironment': {
            'sub_topics': ['TME_modulation', 'radiosensitizers',
                          'multi_modal_approaches', 'immunosuppression_reversal',
                          'sequential_therapy_optimization'],
            'key_metrics': ['synergy_assessment', 'survival_benefit',
                           'toxicity_profile', 'quality_of_life'],
            'pattern_focus': 'single_vs_combination_efficacy, optimal_sequencing'
        }
    }
    
    # Research execution pattern
    confidence_threshold = 0.70
    search_queries = []
    
    for domain, config in research_domains.items():
        for sub_topic in config['sub_topics']:
            query = f"{sub_topic} {disease_name} clinical trial results 2023 2024"
            search_queries.append(query)
    
    # Pattern identification framework
    universal_patterns = [
        'local_delivery_vs_systemic_efficacy',
        'combination_vs_monotherapy_outcomes',
        'neoadjuvant_timing_advantage',
        'heterogeneity_driven_resistance',
        'microenvironment_immunosuppression_effect'
    ]
    
    # Confidence scoring
    confidence_levels = {
        'phase_III_positive': 0.90,
        'phase_II_positive': 0.75,
        'phase_I_safe': 0.60,
        'preclinical_promising': 0.40,
        'case_reports': 0.30
    }
    
    return {
        'disease': disease_name,
        'research_domains': research_domains,
        'search_queries': search_queries,
        'pattern_framework': universal_patterns,
        'confidence_scoring': confidence_levels,
        'synthesis_method': 'confidence_weighted_pattern_analysis'
    }